Indivior Pharmaceuticals, Inc. (INDV) — Revenue

Annual figures by fiscal year, from SEC filings.

2022: $901.00M2023: $1.09B2024: $1.19B2025: $1.24B$1.24B
2022Revenue (USD)2025
Fiscal YearRevenueChange YoY
2025$1.24B+4.3%
2024$1.19B+8.7%
2023$1.09B+21.3%
2022$901.00M